Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000930 · ClinicalTrials.gov registry record
A Study of HIV in Newly Infected Individuals
A clinical trial of HIV Infections, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 12
- Study locations
NCT00000930 is a study of HIV Infections that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The trial reports 12 study locations across 9 states.
The verdict
NCT00000930, a study of HIV Infections, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 12
- Study locations
Study Summary
The purpose of this study is to see how HIV reacts in the immune systems of patients who have recently been infected with HIV. This study also examines HIV's resistance to anti-HIV drugs in newly infected patients. Certain populations are good candidates for participation in HIV vaccine trials. These groups include men who have sex with men, IV drug users, and women at risk of getting HIV through heterosexual contact. Learning how HIV behaves in these populations once they become infected can help with the planning of future HIV vaccine studies.
Conditions Studied
Study Locations (12)
New York
- New York Univ Med Ctr - New York
- Bronx-Lebanon Hosp Ctr - The Bronx
- New York Blood Ctr - The Bronx
California
- Los Angeles County / Health Research Assoc / Drew Med Ctr - Los Angeles
- San Francisco Dept of Hlth / AIDS Office - San Francisco
Colorado
- Denver Dept of Public Health / HIVNET - Denver
Illinois
- Univ of Illinois Chicago / Howard Brown Hlth Ctr - Chicago
Maryland
- Johns Hopkins Univ - Baltimore
Massachusetts
- Fenway Community Health Ctr / HIVNET - Boston
Pennsylvania
- Univ of Pennsylvania / HIVNET - Philadelphia
Rhode Island
- Miriam Hosp - Providence
Trial Details
| Field | Value |
|---|---|
| Est. Completion | 2008-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000930
The ClinicalTrials.gov registry entry for NCT00000930 describes a study currently listed as completed, categorized as an unspecified phase. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.
NCT00000930 reports 12 study locations spanning 9 distinct geographic areas - top geographies include New York, California, Colorado.
Frequently Asked Questions
What is clinical trial NCT00000930 about?
NCT00000930 is a clinical study titled "A Study of HIV in Newly Infected Individuals". The purpose of this study is to see how HIV reacts in the immune systems of patients who have recently been infected with HIV. This study also examines HIV's resistance to anti-HIV drugs in newly infected patients. Certain populations are good candidates for participation in HIV vaccine trials. The...
What is the current status of trial NCT00000930?
This trial is currently completed. Estimated completion is 2008-05.
What conditions does trial NCT00000930 study?
This clinical trial studies the following conditions: HIV Infections.
Who is sponsoring clinical trial NCT00000930?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00000930 being conducted?
This trial has 12 study locations across California, Colorado, Illinois, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
CAR-T Cells for HIV Infection
RECRUITING · Phase 1
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
RECRUITING · Phase 1
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.